2004-08-01
Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors
Publication
Publication
Investigational New Drugs: the journal of new anti-cancer agents , Volume 22 - Issue 3 p. 329- 333
Additional Metadata | |
---|---|
, , , | |
doi.org/10.1023/B:DRUG.0000026260.24275.02, hdl.handle.net/1765/69844 | |
Investigational New Drugs: the journal of new anti-cancer agents | |
Organisation | Department of Medical Oncology |
de Jonge, M., Droz, J.-P., Paz-Ares, L., van Oosterom, A., de Wit, R., Chollet, P., … Fumoleau, P. (2004). Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors. Investigational New Drugs: the journal of new anti-cancer agents, 22(3), 329–333. doi:10.1023/B:DRUG.0000026260.24275.02 |